JPMorgan Emerg. EMEA - Holding(s) in Company

JPMorgan Emerging Europe Middle East & Africa Securities

26/11/2025 15:35

RNS Number : 1531J

JPMorgan Emerging EMEA Securities

26 November 2025

 

TR-1: Standard form for notification of major holdings 

ISIN 

GB0032164732 

Issuer Name 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC  

UK or Non-UK Issuer 

UK 

An acquisition or disposal of voting rights 

Name 

Whitefort Capital Management, LP 

City of registered office (if applicable) 

Wilmington, Delaware 

Country of registered office (if applicable) 

United States 

Name
City of registered office
Country of registered office
David Salanic
N/A
N/A
Joseph Kaplan
N/A
N/A

Name
City of registered office
Country of registered office
Whitefort Capital Master Fund, LP
Grand Cayman
Cayman Islands

12-Nov-2025 

13-Nov-2025 

% of voting rights attached to
% of voting rights through financial
Total of both in % (8.A + 8.B)
Total number of voting
shares (total of
8.A)
instruments (total of 8.B 1 + 8.B 2)
rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
18.800000
0.000000
18.800000
7591473
Position of previous notification (if applicable)
14.240000
0.000000
14.240000


Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB0032164732
7591473
18.800000
Sub Total 8.A
7591473
18.800000%

Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1


Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2


2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary) 

Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is
Total of both if it equals or is higher than the notifiable threshold
higher than the notifiable threshold
David Salanic
Safida LLC (1)
18.800000
18.800000%
Joseph Kaplan
JK Advisors LLC
(1)
18.800000
18.800000%
David Salanic
WHITEFORT
CAPITAL
MANAGEMENT,
LP (2)
18.800000
18.800000%
Joseph Kaplan
WHITEFORT
CAPITAL
MANAGEMENT,
LP (2)
18.800000
18.800000%
David Salanic
WHITEFORT
CAPITAL GP,
LLC (3)
18.800000
18.800000%
Joseph Kaplan
WHITEFORT
CAPITAL GP,
LLC (3)
18.800000
18.800000%
David Salanic
WHITEFORT
CAPITAL
MASTER FUND,
LP (4)
18.800000
18.800000%
Joseph Kaplan
WHITEFORT
CAPITAL
MASTER FUND,
LP (4)
18.800000
18.800000%

Name of the proxy holder 



The number and % of voting rights held 



The date until which the voting rights will be held 



Whitefort Capital Master Fund, LP's general partner is Whitefort Capital 

GP, LLC (the "GP"). The GP has delegated voting rights to Whitefort  Capital Management, LP (the "Manager") pursuant to an investment  management agreement. The Manager is controlled jointly by (1) Safida,  LLC, which is, in turn, controlled by David Salanic, and (2) JK Advisors,  LLC, which is, in turn, controlled by Joseph Kaplan. 

13-Nov-2025

New York, NY, USA 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
HOLUNOVRVUUAUAA